(Q46789871)

25 December 2017

title

Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity (English)

1 reference

25 December 2017

author name string

Kim SM

1

1 reference

25 December 2017

Lee J

2

1 reference

25 December 2017

Ryu OH

3

1 reference

25 December 2017

Lee KW

4

1 reference

25 December 2017

Kim HY

5

1 reference

25 December 2017

Seo JA

6

1 reference

25 December 2017

Kim SG

7

1 reference

25 December 2017

Kim NH

8

1 reference

25 December 2017

Baik SH

9

1 reference

25 December 2017

Choi DS

10

1 reference

25 December 2017

Choi KM

11

1 reference

25 December 2017

publication date

1 November 2005

1 reference

25 December 2017

published in

Clinical Endocrinology

1 reference

25 December 2017

volume

63

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

594-598

1 reference

25 December 2017

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Inflammation in atherosclerosis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Osteoprotegerin and diabetic macroangiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02390.X

10.1111/J.1365-2265.2005.02390.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017